The only adult hepatitis B vaccine for the US market approved by the FDA in 2018
According to the Shanghai news article, it was reported recently, Dynavax announced the FDA approval of its hepatitis B vaccine HEPLISAV-B for the prevention of infection in adults over 18 years all known subtypes of hepatitis B virus caused. HEPLISAV-B is the United States 25 years the first new hepatitis B vaccine and the only one pair of adult dose for hepatitis B vaccine, the first quarter of 2018 is expected to be available in the United States. Our market is mainly in the neonatal hepatitis B vaccine inoculation, with the two-child policy liberalization, the market size further amplification. Concern Hualan, happy and healthy life.
NewsEuropean and American pornographic actress data Alisa
2017-11-20Aix XinLe10
NewsNearly half of Europe no room who do not expect to buy a house
2017-11-12Aix XinLe29
ING Group (ING) A recent survey found that nearly half of those who believe that Europe no room in this life to buy a house hopeless.ING conducted on the national survey of 13 European countries, found that 48% believe no room in this life can not afford…
NewsISIS has lost 98 percent of its territory -- mostly since Trump took office, officials say
2017-12-29Aix XinLe32
NewsThe world's ten busiest airport half of total ban
2017-11-26Aix XinLe8
The United States Centers for Disease Control and prevention, 22, released a report that ten of the world's most busiest airport in half a total ban, including Beijing Capital International Airport and Shanghai Pudong International Airport…